The estimated Net Worth of Nancy Lynn Md Snyderman is at least $846 Mille dollars as of 29 June 2024. Nancy Snyderman owns over 6,104 units of Axonics Inc stock worth over $419,528 and over the last 8 years he sold AXNX stock worth over $0. In addition, he makes $426,450 as Independent Director at Axonics Inc.
Sign up
Nancy Snyderman AXNX stock SEC Form 4 insiders trading
Nancy has made over 8 trades of the Axonics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 6,104 units of AXNX stock worth $419,528 on 29 June 2024.
The largest trade he's ever made was exercising 7,585 units of Axonics Inc stock on 14 June 2022 worth over $521,317. On average, Nancy trades about 1,199 units every 63 days since 2016. As of 29 June 2024 he still owns at least 6,104 units of Axonics Inc stock.
You can see the complete history of Nancy Snyderman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Nancy Snyderman biography
Dr. Nancy Lynn Snyderman M.D. serves as Independent Director of the Company. Dr. Snyderman has served as an independent director on the board of directors of Alkermes plc (NASDAQ: ALKS) and as a member of the nominating and corporate governance committee since 2016. Dr. Snyderman was an advisory board member to GE’s Healthymagination for twelve years and previously served as a vice president for corporate communications at Johnson & Johnson. Dr. Snyderman is a board-certified head and neck surgeon and has had academic appointments at the University of Pennsylvania and the University of California-San Francisco. She recently served as a professor at the Center for Innovation for Global Health at Stanford University. Dr. Snyderman is an Emmy award winning medical correspondent having worked at ABC News from 1987 to 2003 and later as chief medical editor at NBC News from 2004 to 2015. She has been widely published in peer-reviewed medical journals and has written for Good Housekeeping, AARP, Parenting, Health, and O magazines. Dr. Snyderman is an advocate for women’s health and a prolific public speaker and presently serves on the board of directors of Fair Food Network and the Albright Institute at Wellesley College. Dr. Snyderman holds a B.A. in microbiology from Indiana University and a M.D. from the University of Nebraska and has completed residencies in Pediatrics and Otolaryngology Head and Neck Surgery at the University of Pittsburgh. Snyderman’s extensive experience as a physician, advisor for, and director of medical device companies qualifies her to serve on our Board.
What is the salary of Nancy Snyderman?
As the Independent Director of Axonics Inc, the total compensation of Nancy Snyderman at Axonics Inc is $426,450. There are 13 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of $6,147,640.
How old is Nancy Snyderman?
Nancy Snyderman is 68, he's been the Independent Director of Axonics Inc since 2019. There are no older and 21 younger executives at Axonics Inc.
Insiders trading at Axonics Inc
Over the last 6 years, insiders at Axonics Inc have traded over $108,010,643 worth of Axonics Inc stock and bought 4,672,163 units worth $70,180,620 . The most active insiders traders include Asset Management, Lp Chen B..., Shahzad Malik e Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of $4,280,711. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth $2,383,374.
What does Axonics Inc do?
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
What does Axonics Inc's logo look like?
Complete history of Nancy Snyderman stock trades at Alkermes plc, Axonics Inc e Lyra Therapeutics
Axonics Inc executives and stock owners
Axonics Inc executives and other stock owners filed with the SEC include:
-
Raymond Cohen,
Chief Executive Officer, Director -
Dan Dearen,
President, Chief Financial Officer -
Rinda Sama,
Chief Operating Officer -
Raymond W. Cohen,
CEO & Director -
Danny L. Dearen,
Pres & CFO -
Dr. Karen L. Noblett M.D., M.A.S.,
Chief Medical Officer -
Rinda K. Sama,
Chief Operating Officer -
Robert McNamara,
Independent Director -
Juliet Tammenoms Bakker,
Independent Director -
Alfred J. Ford Jr.,
Chief Commercial Officer -
Erik Amble,
Independent Director -
Michael Carrel,
Independent Chairman of the Board -
Jane Kiernan,
Independent Director -
Nancy Snyderman,
Independent Director -
Karen Noblett,
Chief Medical Officer -
Prabodh Mathur,
Chief Product Development Officer -
Alfred Ford,
Chief Commercial Officer -
John Woock,
Chief Marketing Officer -
Dr. Karen L. Noblett M.A.S., M.D.,
Chief Medical Officer -
Michael V. Williamson Esq., J.D.,
Sr. VP, Gen. & IP Counsel -
Michael V. Williamson,
Sr. VP, Gen. & IP Counsel -
Dr. John Woock Ph.D.,
Exec. VP, Chief Marketing & Strategy Officer -
Aaron Pettit,
Gen. Counsel & Chief Compliance Officer -
Neil Bhalodkar,
VP of Investor Relations -
Guangqiang Jiang Ph.D.,
Chief Technology Officer -
Esteban Lopez,
-
John George Petrovich,
Director -
Shahzad Malik,
Director -
Life Sciences Llp Advent Li...,
-
Partners Bio Discovery 4 Fc...,
-
E. Mann Foundation For Scie...,
-
Capital Partners Iii, Llcen...,
-
Innovation V Ltd Neo Med In...,
-
Healthcare Holding B.V.Gild...,
-
Asset Management, Lp Chen B...,
-
Michael V. Williamson,
SVP, General Counsel -
Guangqiang Jiang,
Chief Technology Officer -
Zhong Zac & Cloud Holdings ...,
-
Raphael Wisniewski,
-
Robert E Mcnamara,
-
Geoff Pardo,
-
David M Demski,
-
Kari Leigh Keese,
Chief Financial Officer